FS Bancorp Stock (NASDAQ:FSBW), Trade Ideas

FS Bancorp

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Price Target

Small Cap

Pre-Market Outlook

Analyst Ratings

CELH

Embraer-Empresa Brasileira De Aeronautica

FSBW

Morgan Stanley Capital Protected Notes for S&P 500 Index

OCGN

PRTA

SNOW

VRTX


	Barclays lowered  Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.


10 Biggest Price Target Changes For Friday

News

Intraday Update

Markets

Movers

Trading Ideas

ABCB

ABEV

ACAM

ACBI

ACCO

ACEL

ACER

ACIW

ACLS

ACRS

ACST

ADOM

AEHR

AGRO

AIMC

AINV

AIRT

ALEX

ALGN

ALGT

ALOT

AMAL

AMKR

AMOT

AMPH

AMRB

AMSC

AMWD

ANIK

ANIX

AOSL

APEN

APLE

APOG

APPN

APYX

AQUA

ARCC

ARCO

ARDC

ARDS

ARKR

AROW

ARPO

ASRV

ATKR

ATRS

AVAL

AVNW

AWSM

AXNX

AZUL

Stocks That Hit 52-Week Lows On Thursday

AACG

AAOI

ABMD

ACGL

ACHC

ACHV

ACIU

ACRE

ACRX

ACTG

ADES

ADMP

ADMS

ADNT

ADPT

ADTN

AEIS

AERI

AEZS

AFGC

AFIN

AFMD

AGFS

AGLE

AGYS

AIMT

AKCA

AKTS

AKTX

ALBO

ALDX

Stocks That Hit 52-Week Lows On Monday

FS Bancorp Inc

<p>DA Davidson  analyst Tom White   maintains eXp World Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPI#NASDAQ">EXPI</a>) with a Underperform and lowers the price target from $13 to $11.75.</p>


EXPI

DA Davidson Maintains Underperform on eXp World Holdings, Lowers Price Target to $11.75

WIIM

BNTX

Pfizer and BioNTech shares are trading lower amid reports GSK is suing the companies alleging patent infringement concerning mRNA technology used in their COVID-19 vaccines.

<p>Financial giants have made a conspicuous bearish move on RTX. Our analysis of options history for RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) revealed 14 unusual trades.</p>
<p>Delving into the details, we found 28% of traders were bullish, while 64% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $262,150, and 11 were calls, valued at $1,140,666.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $120.0 for RTX over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for RTX's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of RTX's whale trades within a strike price range from $80.0 to $120.0 in the last 30 days. </p>
<h3>RTX 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714073618_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.5</td>
<td>$6.35</td>
<td>$6.4</td>
<td>$105.00</td>
<td>$640.0K</td>
<td>6.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>RTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.1</td>
<td>$6.8</td>
<td>$7.0</td>
<td>$95.00</td>
<td>$210.0K</td>
<td>419</td>
<td>10</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$1.2</td>
<td>$1.16</td>
<td>$1.18</td>
<td>$120.00</td>
<td>$94.4K</td>
<td>959</td>
<td>801</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$1.46</td>
<td>$1.38</td>
<td>$1.38</td>
<td>$110.00</td>
<td>$90.6K</td>
<td>15.3K</td>
<td>2.1K</td>
</tr>
<tr>
<td>RTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$1.49</td>
<td>$1.48</td>
<td>$1.48</td>
<td>$110.00</td>
<td>$74.0K</td>
<td>15.3K</td>
<td>859</td>
</tr>
</tbody>
</table>
</p>
<h3>About RTX</h3>
<p>RTX is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufacturers and to the defense market. The company operates in three segments: Collins Aerospace, a diversified aerospace supplier; Pratt &amp; Whitney, an aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.</p>
<p>Having examined the options trading patterns of RTX, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is RTX Standing Right Now?</h3>
<ul>
<li>With a volume of 3,912,339, the price of RTX is up 0.76% at $101.79. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 89 days.</li>
</ul>
<h3>What Analysts Are Saying About RTX</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $111.8.</p>
<ul>
<li>An analyst from B of A Securities persists with their Neutral rating on RTX, maintaining a target price of $110. </li>
<li>An analyst from Wells Fargo persists with their Overweight rating on RTX, maintaining a target price of $120. </li>
<li>Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for RTX, targeting a price of $105. </li>
<li>An analyst from Susquehanna has decided to maintain their Positive rating on RTX, which currently sits at a price target of $119. </li>
<li>Maintaining their stance, an analyst from Baird continues to hold a Neutral rating for RTX, targeting a price of $105. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest RTX options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

A Closer Look at RTX's Options Market Dynamics

<p>Financial giants have made a conspicuous bearish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 43 unusual trades.</p>
<p>Delving into the details, we found 41% of traders were bullish, while 51% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $714,621, and 29 were calls, valued at $1,325,211.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $100.0 to $500.0 for CrowdStrike Holdings over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for CrowdStrike Holdings's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CrowdStrike Holdings's whale activity within a strike price range from $100.0 to $500.0 in the last 30 days. </p>
<h3>CrowdStrike Holdings Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714073612_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$26.0</td>
<td>$25.2</td>
<td>$25.75</td>
<td>$240.00</td>
<td>$128.7K</td>
<td style="text-align: right;">221</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$48.0</td>
<td>$47.8</td>
<td>$47.8</td>
<td>$300.00</td>
<td>$109.9K</td>
<td style="text-align: right;">443</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$5.85</td>
<td>$5.7</td>
<td>$5.7</td>
<td>$275.00</td>
<td>$107.1K</td>
<td style="text-align: right;">901</td>
<td style="text-align: right;">27</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$200.85</td>
<td>$198.35</td>
<td>$199.52</td>
<td>$100.00</td>
<td>$99.7K</td>
<td style="text-align: right;">153</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$26.95</td>
<td>$26.85</td>
<td>$26.9</td>
<td>$500.00</td>
<td>$96.6K</td>
<td style="text-align: right;">71</td>
<td style="text-align: right;">113</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>After a thorough review of the options trading surrounding CrowdStrike Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of CrowdStrike Holdings</h3>
<ul>
<li>With a trading volume of 1,390,262, the price of CRWD is up by 0.15%, reaching $298.08.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<h3>What Analysts Are Saying About CrowdStrike Holdings</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $392.0.</p>
<ul>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $400.</li>
<li>An analyst from Rosenblatt has decided to maintain their Buy rating on CrowdStrike Holdings, which currently sits at a price target of $400. </li>
<li>Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for CrowdStrike Holdings, targeting a price of $376. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest CrowdStrike Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


CRWD

CrowdStrike Holdings Unusual Options Activity

<p>Financial giants have made a conspicuous bullish move on Edwards Lifesciences. Our analysis of options history for Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) revealed 11 unusual trades.</p>
<p>Delving into the details, we found 54% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $271,805, and 6 were calls, valued at $465,700.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $82.5 and $97.5 for Edwards Lifesciences, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Edwards Lifesciences's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Edwards Lifesciences's substantial trades, within a strike price spectrum from $82.5 to $97.5 over the preceding 30 days.</p>
<h3>Edwards Lifesciences Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714073607_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>EW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$9.0</td>
<td>$8.4</td>
<td>$9.0</td>
<td>$92.50</td>
<td>$270.0K</td>
<td>14</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>EW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$11.4</td>
<td>$11.3</td>
<td>$11.4</td>
<td>$97.50</td>
<td>$76.3K</td>
<td>15</td>
<td style="text-align: right;">68</td>
</tr>
<tr>
<td>EW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$7.4</td>
<td>$7.3</td>
<td>$7.4</td>
<td>$92.50</td>
<td>$73.2K</td>
<td>102</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>EW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$6.9</td>
<td>$7.3</td>
<td>$87.50</td>
<td>$73.0K</td>
<td>36</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>EW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$1.1</td>
<td>$0.95</td>
<td>$0.96</td>
<td>$95.00</td>
<td>$72.0K</td>
<td>5.0K</td>
<td style="text-align: right;">751</td>
</tr>
</tbody>
</table>
</p>
<h3>About Edwards Lifesciences</h3>
<p>Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.</p>
<p>After a thorough review of the options trading surrounding Edwards Lifesciences, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Edwards Lifesciences Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 2,670,327, the EW's price is down by -0.41%, now at $88.25. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>Expert Opinions on Edwards Lifesciences</h3>
<p>Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $99.0.</p>
<ul>
<li>Maintaining their stance, an analyst from Mizuho continues to hold a Buy rating for Edwards Lifesciences, targeting a price of $105. </li>
<li>Consistent in their evaluation, an analyst from Evercore ISI Group keeps a In-Line rating on Edwards Lifesciences with a target price of $92. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for Edwards Lifesciences, targeting a price of $98. </li>
<li>An analyst from RBC Capital persists with their Outperform rating on Edwards Lifesciences, maintaining a target price of $101. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Edwards Lifesciences, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?

Oil is trading higher despite a drop in US GDP. On Wednesday, EIA reported a draw in US crude inventories.

MAG Silver shares are trading higher after HC Wainwright maintained a Buy rating on the stock and raised its price target from $16 to $17.

<p>WBB Securities analyst Stephen Brozak maintains Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Strong Buy, adjusts target to $40 (reverse stock split - 1:20).</p>


CDTX

WBB Securities Maintains Strong Buy on Cidara Therapeutics, Adjusts Price Target To $40 (reverse stock split - 1:20)

SMCI

Super Micro Computer shares are trading higher after Meta increased its capex outlook amid AI efforts.

ANET

Arista Networks shares are trading higher in reaction to Meta's increased capex for its AI efforts.

FBNC

First Bancorp shares are trading lower after the company reported worse-than-expected Q1 EPS results.

DELL

Dell shares are trading higher in reaction to Meta's increased capex guidance.

<p><a href="https://www.cbsnews.com/60-minutes/">https://www.cbsnews.com/60-minutes/</a></p>
<p>&nbsp;</p>


Events

NVDA

60 Minutes (@60Minutes) Posts On X "One Of Only Five Companies To Ever Surpass $2 Trillion In Stock Market Value, Computer Chip Maker Nvidia Ushered In The Artificial Intelligence Revolution With Its Groundbreaking Software And Graphics Processing Unit. @BillWhitaker Reports, Sunday"

<p>Garry&#8217;s Mod, a popular sandbox game born from Valve&#8217;s Source software modding scene in 2006, faces a significant overhaul due to takedown notices from <a href="https://www.benzinga.com/general/gaming/24/04/38302723/unveiling-nintendos-april-2024-indie-world-showcase-whats-in-store"><strong>Nintendo ADR </strong>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/NTDOY#OTC">NTDOY</a>). </a></p>
<p>Facepunch Studios, the developers, are forced to remove approximately 20 years&#8217; worth of Nintendo-related content from the game.</p>
<p>&#8220;This is not a mistake, the takedowns came from Nintendo,&#8221; an <a href="https://store.steampowered.com/news/app/4000/view/4200245595694413052?l=english">update</a> on Garry&#8217;s Mod&#8217;s Steam page said. &#8220;This is Nintendo's content and what they allow and don't allow is up to them.&#8221;</p>
<p><em>See Also: <a href="https://www.benzinga.com/general/gaming/24/02/37375657/yuzu-emulator-under-fire-nintendo-sues-over-alleged-1-million-pre-release-zelda-downloads">Yuzu Emulator Under Fire &#8211; Nintendo Sues Over Alleged 1 Million Pre-Release Zelda Downloads</a></em></p>
<p>The sudden enforcement by Nintendo is surprising, considering Nintendo-themed content has been part of Garry&#8217;s Mod for nearly two decades, Kotaku <a href="https://kotaku.com/nintendo-garrys-mod-takedown-content-1851433656">reported.</a></p>
<p>The flexibility of the Source engine in Garry&#8217;s Mod, coupled with its popularity among gaming YouTubers in the early 2010s, contributed to its widespread appeal. However, Facepunch&#8217;s leniency regarding content moderation likely prompted Nintendo&#8217;s action.</p>
<p>The takedown process began a few months ago, although Facepunch only publicly acknowledged it recently. </p>
<p>Removing all Nintendo-related content is a daunting task, as mentioned humorously by Facepunch: &#8220;If you want to help us by deleting your Nintendo related uploads and never uploading them again, that would help us a lot.&#8221;</p>
<p>Nintendo has a history of vigorously safeguarding its intellectual property rights. Last year, it prompted the removal of the Dolphin Emulator from Steam. </p>
<p>Additionally, Nintendo filed a $2.4 million lawsuit against the developers of the Nintendo Switch emulator Yuzu, resulting in the closure of other emulator projects due to apprehension about legal repercussions from Nintendo.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/general/gaming/24/02/37315458/this-is-the-reason-behind-nintendo-switch-2s-delay-to-march-2025-report-says" target="_blank" rel="noreferrer noopener">This Is The Reason Behind Nintendo Switch 2&#8217;s Delay To March 2025, Report Says</a></em></p>
<p><em>Image created using photos from Wikipedia and Shutterstock.</em></p>


Gaming

NTDOY

Garry's Mod Under Fire: Nintendo Orders Massive Content Purge

<p>Barrington Research  analyst Alexander Paris   maintains Strategic Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRA#NASDAQ">STRA</a>) with a Outperform and raises the price target from $125 to $135.</p>


STRA

Barrington Research Maintains Outperform on Strategic Education, Raises Price Target to $135

<p>JonesTrading  analyst Jason Weaver   maintains Annaly Capital Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) with a Buy and maintains $21 price target.</p>


JonesTrading Maintains Buy on Annaly Capital Management, Maintains $21 Price Target

<p>Barrington Research  analyst James Goss   maintains Imax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) with a Outperform and maintains $24 price target.</p>


IMAX

Barrington Research Maintains Outperform on Imax, Maintains $24 Price Target

<p>In an era of blossoming cannabis markets, North America stands out with significant milestones as Massachusetts and Canada reveal positive sales figures.</p>
<h3 class="wp-block-heading"><strong>Massachusetts&#8217; Green Milestone: Surpassing $6 Billion</strong></h3>
<p><a href="https://www.benzinga.com/topic/massachusetts-cannabis">Massachusetts</a> has set an impressive record, with cannabis establishments collectively <strong>crossing the $6 billion threshold in gross sales</strong>. Not surprisingly, a single-day sales record was smashed on April 20, as cannabis enthusiasts celebrated, amassing $8.5 million in transactions, <a href="https://masscannabiscontrol.com/2024/04/massachusetts-marijuana-establishments-surpass-6-billion-in-gross-sales-in-lead-up-to-4-20-and-set-single-sales-day-record-on-consumer-holiday/" target="_blank" rel="noreferrer noopener">noted</a> a press release from the Cannabis Control Commission (CCC). This robust growth signals not just a triumph for the industry but also for the economic and regulatory frameworks in place.</p>
<p>"I continue to be encouraged by these sales milestones because they show that the industry is strong and efficiently regulated, both spurring economic development and critical tax revenue for the Commonwealth and providing safe, tested products for consumers and patients alike," said <strong>Ava Callender Concepcion</strong>, acting chair of the CCC.</p>
<p><em><strong>Read also:</strong> <a href="https://www.benzinga.com/markets/cannabis/24/04/38022665/massachusetts-cannabis-market-hits-record-highs-faces-regulatory-challenges-and-more" target="_blank" rel="noreferrer noopener">Massachusetts&#8217; Cannabis Market Hits Record Highs, Faces Regulatory Challenges, And More</a></em></p>
<p>According to the CCC's sales and product distribution <a href="https://masscannabiscontrol.com/open-data/sales-and-product-distribution/">data</a>, medical cannabis made $62.5 million in sales in 2024. Massachusetts' delivery operators are also thriving, generating $3.1 million in sales in 2024 and contributing $26.3 million in sales to the state&#8217;s cannabis market since their first deliveries in 2021.</p>
<h3 class="wp-block-heading"><strong>Canada&#8217;s Slow Climb: Provincial Perspectives</strong></h3>
<p>Across the northern border, Canada&#8217;s retail cannabis sales are showing modest growth. According to the latest <a href="https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=2010005601&amp;pickMembers%5B0%5D=2.30&amp;pickMembers%5B1%5D=3.1&amp;pickMembers%5B2%5D=4.1&amp;cubeTimeFrame.startMonth=12&amp;cubeTimeFrame.startYear=2017&amp;cubeTimeFrame.endMonth=05&amp;cubeTimeFrame.endYear=2024&amp;referencePeriods=20171201%2C20240501">release</a> from Statistics Canada, the nation tallied over CA$376 million ($274.9 million) in February 2024 alone, showcasing a resilient industry despite fluctuating global economic currents.</p>
<p><figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="976" height="687" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25142318/canadafeb24.png" alt="" class="wp-image-309428" style="width:553px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25142318/canadafeb24.png 976w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25142318/canadafeb24-300x211.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25142318/canadafeb24-768x541.png 768w" sizes="(max-width: 976px) 100vw, 976px" /><figcaption class="wp-element-caption">Canada&#8217;s monthly cannabis retail sales in millions of CA$&#x7C; Source: Statistics Canada. Table 20-10-0056-01</figcaption></figure></p>
<p>Ontario leads the charge with CA$145,7 million ($106 million), followed closely by Alberta and British Columbia, underscoring a nationwide embrace of cannabis products.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Geography</strong></td>
<td><strong>Feb-23</strong></td>
<td><strong>Feb-24</strong></td>
<td class="has-text-align-center" data-align="center"><strong>YoY Sales Growth %</strong></td>
</tr>
<tr>
<td>Nova Scotia</td>
<td>CA$ 8,4 million</td>
<td>CA$ 12,6 million</td>
<td class="has-text-align-center" data-align="center">49.1%</td>
</tr>
<tr>
<td>Newfoundland and Labrador</td>
<td>CA$ 5,6 million</td>
<td>CA$ 7,0 million</td>
<td class="has-text-align-center" data-align="center">26.3%</td>
</tr>
<tr>
<td>Yukon</td>
<td>CA$ 788 thousand</td>
<td>CA$ 968 thousand</td>
<td class="has-text-align-center" data-align="center">22.8%</td>
</tr>
<tr>
<td>Manitoba</td>
<td>&nbsp;CA$ 14,3 million</td>
<td>CA$ 16,8 million</td>
<td class="has-text-align-center" data-align="center">17.2%</td>
</tr>
<tr>
<td>New Brunswick</td>
<td>CA$ 6,1 million</td>
<td>CA$ 7,0 million</td>
<td class="has-text-align-center" data-align="center">14.9%</td>
</tr>
<tr>
<td>Prince Edward Island</td>
<td>CA$ 1,7 million</td>
<td>CA$ 1,9 million</td>
<td class="has-text-align-center" data-align="center">12.2%</td>
</tr>
<tr>
<td>Alberta</td>
<td>CA$ 65,0 million</td>
<td>CA$ 72,0 million</td>
<td class="has-text-align-center" data-align="center">10.8%</td>
</tr>
<tr>
<td>Quebec</td>
<td>CA$ 45,1 million</td>
<td>CA$ 49,0 million</td>
<td class="has-text-align-center" data-align="center">8.5%</td>
</tr>
<tr>
<td>Saskatchewan</td>
<td>CA$ 13,5 million</td>
<td>CA$ 13,4 million</td>
<td class="has-text-align-center" data-align="center">-0.4%</td>
</tr>
<tr>
<td>Ontario</td>
<td>CA$ 151,1 million</td>
<td>CA$ 145,7 million</td>
<td class="has-text-align-center" data-align="center">-3.6%</td>
</tr>
<tr>
<td>British Columbia</td>
<td>CA$ 56,8 million</td>
<td>&nbsp;CA$ 48,3 million</td>
<td class="has-text-align-center" data-align="center">-15.0%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption">Source: Statistics Canada. Sales for the Northwest Territories and Nunavut regions were not added to the report.</figcaption></p></figure></p>
<p>However, despite the 1.7% year-over-year growth in the cannabis sector, <a href="https://www.benzinga.com/topic/canada-cannabis">Canada&#8217;s sales</a> have seen a downtrend for the second consecutive month:</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall-1024x456.png" alt="" class="wp-image-309448" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall-1024x456.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall-300x134.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall-768x342.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall-1536x684.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/25143828/canadaall.png 1541w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Canada monthly cannabis retail sales in millions of CA$&#x7C; Source: Statistics Canada. Table 20-10-0056-01</figcaption></figure></p>
<p>As Canada grapples with a two-month sales dip and Massachusetts celebrates its record sales, these fluctuations depict a nuanced canvas of North America&#8217;s cannabis industry, evolving with consumer trends and regulatory landscapes.</p>
<p><em><strong>Read also:</strong> <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38420095/cannabis-companies-gains-u-s-versus-canada-averages-can-be-deceiving-irrational-mar" target="_blank" rel="noreferrer noopener">Cannabis Companies&#8217; Gains &#8211; U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?</a></em></p>


Cannabis

Retail Sales

Massachusetts Cannabis Sales Soar Past $6B Record, Canada Sees Steady 1.7% Year-Over-Year Growth

<p><strong>Boise Cascade's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCC#NYSE">BCC</a>) short percent of float has fallen 15.29% since its last report. The company recently reported that it has <strong>1.16 million shares sold short</strong>, which is 4.32% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.24 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Boise Cascade Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714072524_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Boise Cascade has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Boise Cascade's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Boise Cascade's peer group average for short interest as a percentage of float is 4.21%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

How Is The Market Feeling About Boise Cascade?

<p><strong>Seagate Tech Hldgs's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STX#NYSE">STX</a>) short percent of float has fallen 6.4% since its last report. The company recently reported that it has <strong>8.80 million shares sold short</strong>, which is 5.12% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.89 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Seagate Tech Hldgs Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714072518_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Seagate Tech Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Seagate Tech Hldgs's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Seagate Tech Hldgs's peer group average for short interest as a percentage of float is 6.37%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


(STX) - Analyzing Seagate Tech Hldgs's Short Interest

Dividend Champion, Contender, And Challenger Highlights: Week Of January 28

13 Upcoming Dividend Increases

Dividend Champion, Contender, And Challenger Highlights: Week Of February 4

Dividend Champion, Contender, And Challenger Highlights: Week Of February 18

FS Bancorp Inc (FSBW) has issued an announcement. FS Bancorp, Inc. executives, EVP Matthew D. Mullet and Erin Burr, are set to attend Piper Sandler...

FS Bancorp Executives Present at Western Financial Conference

FS Bancorp Inc (FSBW) has issued an update. FS Bancorp, Inc. and 1st Security Bank of Washington have announced the departure of Stephanie Nicklaus...

FS Bancorp Announces Chief Credit Officer's Departure

<strong><i>The U.S. banking industry is showing signs of recovery due to stabilizing asset quality, potential rate cuts this year, and lower expense growth. Therefore, investors could consider buying fundamentally strong bank stocks Capital Bancorp (CBNK), FS Bancorp (FSBW), and Old Point Financial (OPOF). Read more...</i></strong><br><br><p>The U.S. banking industry's outlook looks stable after last year's challenges. Greater certainty around interest rates, manageable asset quality pressures, and expected regulatory improvements provide optimism for the industry.</p>
<p>Therefore, investors could consider buying fundamentally strong bank stocks: Capital Bancorp, Inc. (<a href="https://stocknews.com/stock/CBNK/">CBNK</a>), FS Bancorp, Inc. (<a href="https://stocknews.com/stock/FSBW/">FSBW</a>), and Old Point Financial Corporation (<a href="https://stocknews.com/stock/OPOF/">OPOF</a>).</p>
<p>Before diving deeper into the fundamentals of these stocks, let's discuss what's going on in the banking industry.</p>
<p>Since last year, regional banks faced challenges such as deposit outflows, higher deposit costs, credit rating downgrades, funding cost pressures. However, the U.S. banking industry has rebounded strongly following last year's bank failures, demonstrating increased stability, a positive performance outlook, and capital growth potential.</p>
<p>The banking industry still faces risks of default on commercial real estate (CRE) loans, economic uncertainty, higher funding costs, and stringent lending standards, but banks are expected to maintain good profitability, with a return on common equity of <a href="https://www.spglobal.com/_assets/documents/ratings/research/101591972.pdf">10% - 11%</a>.</p>
<p>Although banks' net interest income (NII) will likely decline this year, they will likely build capital through earnings retention as they prepare for stricter norms. Moreover, banks are expected to manage asset quality challenges with sufficient pre-provisioning to absorb expected credit losses.</p>
<p>According to Fitch Ratings, <a href="https://www.fitchratings.com/research/banks/us-banks-lower-expense-growth-to-mitigate-margin-pressure-in-2024-13-02-2024">potential fee income improvement</a>, eventual stabilization in asset quality, and contained expense growth will support the financial performance of banks toward the latter part of 2024.</p>
<p>Furthermore, the Federal Reserve's expected rate cuts this year will benefit banks. Lower interest rates can stimulate borrowing and investment, increase demand for loans, and positively impact banks' interest income. Moreover, lower interest rates will decrease banks' cost of borrowing to fund loans and other transactions.</p>
<p>Considering these conducive trends, let's analyze the fundamental aspects of the three bank stocks.</p>
<p><strong>Capital Bancorp, Inc. </strong>(<a href="https://stocknews.com/stock/CBNK/"><strong>CBNK</strong></a><strong>)</strong></p>
<p>CBNK operates as the bank holding company for Capital Bank, N.A., and provides various banking products and services to businesses, not-for-profit associations, and entrepreneurs in Maryland, Virginia, and the District of Columbia. It operates through the Commercial Banking, Capital Bank Home Loans, and OpenSky segments.</p>
<p>In terms of the trailing-12-month Return on Common Equity, CBNK's 14.98% is 37.1% higher than the 10.93% industry average. Its 1.61% trailing-12-month <a href="https://www.investopedia.com/terms/r/returnonassets.asp">Return on Total Assets</a> is 46.6% higher than the 1.10% industry average.</p>
<p>CBNK's net interest income for the fourth quarter ended December 31, 2023, came in at $34.89 billion. The company's adjusted net income rose marginally year-over-year to $9.03 million. Its EPS rose 4.8% over the prior-year quarter to $0.65. In addition, its adjusted average total assets stood at $2.20 billion, up 3.2% from the year-ago value.</p>
<p>Analysts expect CBNK's revenue for the quarter ending March 31, 2024, to increase marginally year-over-year to $40.70 million. Its EPS for the quarter ending June 30, 2024, is expected to grow 14.2% year-over-year to $0.59. It surpassed the consensus EPS estimates in three of the trailing four quarters. Over the past year, the stock has gained 24.5% to close the last trading session at $20.94.</p>
<p>CBNK's positive outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. It has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.</p>
<p>It is ranked first out of 37 stocks in the <a href="https://stocknews.com/category/mid-atlantic-regional-banks/">Mid-Atlantic Regional Banks</a> industry. It has a B grade for Value, Momentum, Stability, and Sentiment. To access CBNK's grades for Growth and Quality, <a href="https://stocknews.com/stock/CBNK/">click here</a>.</p>
<p><strong>FS Bancorp, Inc. </strong>(<a href="https://stocknews.com/stock/FSBW/"><strong>FSBW</strong></a><strong>)</strong></p>
<p>FSBW operates as a bank holding company for the 1st Security Bank of Washington that provides banking and financial services to local families, local and regional businesses, and industry niches. The company operates in two segments: Commercial and Consumer Banking and Home Lending.</p>
<p>In terms of the trailing-12-month net income margin, FSBW's 25.93% is 9.3% higher than the 23.73% industry average. Its 14.30% trailing-12-month Return on Common Equity is 30.8% higher than the industry average of 10.93%. Likewise, its 1.21% trailing-12-month Return on Total Assets is 10.4% higher than the industry average of 1.10%.</p>
<p>For the fiscal fourth quarter that ended December 31, 2023, FSBW's total interest and dividend income amounted to $44.44 million, up 24.1% year-over-year. Its net income and earnings per share increased 28.2% and 26.8% from the year-ago value to $9.77 million and $1.23, respectively.</p>
<p>In addition, the company's non-GAAP tangible common stockholder's equity grew 7.8% year-over-year to $243.55 million. Also, as of December 31, 2023, its total assets stood at $2.97 billion, compared to $2.63 billion as of December 31, 22.</p>
<p>Street expects FSBW's revenue for the quarter ending September 30, 2024, to increase 1.6% year-over-year to $36.20 million. Its EPS for the fiscal 2025 is expected to increase 9.7% year-over-year to $4.63. It surpassed the Street EPS estimates in three of the trailing four quarters. Over the past six months, the stock has gained 14.4% to close the last trading session at $33.80.</p>
<p>It's no surprise that FSBW has an overall rating of B, which translates to a Buy in our proprietary rating system.</p>
<p>It has a B grade for Value and Sentiment. Within the <a href="https://stocknews.com/category/pacific-regional-banks/">Pacific Regional Banks</a> industry, it is ranked first out of 42 stocks. In total, we rate FSBW on eight different levels. Beyond what we have stated above, we also have given FSBW grades for Growth, Momentum, Stability, and Quality. Get all the FSBW ratings <a href="https://stocknews.com/stock/FSBW/">here</a>.</p>
<p><strong>Old Point Financial Corporation </strong>(<a href="https://stocknews.com/stock/OPOF/"><strong>OPOF</strong></a><strong>) </strong></p>
<p>OPOF operates as the bank holding company for The Old Point National Bank of Phoebus, which provides consumer, mortgage, and business banking services to individual and commercial customers in Virginia. The company offers deposit products, including interest-bearing transaction accounts, money market deposit accounts, savings accounts, time deposits, and demand deposits.</p>
<p>On January 31, 2024, OPOF announced a strategic alliance with Tidewater Home Funding, transitioning mortgage loan processing while maintaining its branding as Old Point Mortgage and expanding mortgage product offerings.</p>
<p>Joseph Witt, President of Financial Services and Chief Strategy Officer at OPOF said, "This strategic alliance between Old Point and Tidewater Home Funding will expand opportunities for both organizations, continue to provide our customers with excellent service and local decision-making, and maximize value to our shareholders."</p>
<p>In terms of the trailing-12-month Capex / Sales margin, OPOF's 2.13% is 4.5% higher than the 2.04% industry average.</p>
<p>OPOF's net interest and dividend income for the fourth quarter that ended December 31, 2023, increased 27% year-over-year to $17.94 million. The company's non-GAAP tangible stockholder's equity grew 8.4% year-over-year to $104.94 million. Its adjusted income stood at $1.48 million and $0.29 per share, respectively.</p>
<p>Over the past nine months, the stock has gained 2.2% to close the last trading session at $16.20.</p>
<p>OPOF's strong fundamentals are reflected in its POWR Ratings. It has a B grade for Growth, Stability, and Sentiment.</p>
<p>It is ranked #2 in the Mid-Atlantic Regional Banks industry. To see OPOF's Value, Momentum, and Quality ratings, <a href="https://stocknews.com/stock/OPOF/">click here</a>.</p>
<p><strong><em>What To Do Next?</em></strong></p>
<p>43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.</p>
<p><strong><a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a></strong></p>

<hr />
<p>CBNK shares were trading at $20.94 per share on Friday afternoon, up $0.50 (+2.45%). Year-to-date, CBNK has declined -13.13%, versus a 10.06% rise in the benchmark S&amp;P 500 index during the same period.</p>
<hr><div style="clear:both;"></div><br><h2>About the Author: Abhishek Bhuyan</h2><br><img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;"><p>Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.</p><p><a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a></p>The post <strong><a href=https://stocknews.com/news/cbnk-fsbw-opof-3-bank-stocks-driving-returns-across-industries/>3 Bank Stocks Driving Returns Across Industries</a></strong> appeared first on <strong><a href=https://stocknews.com/>StockNews.com</a></strong>

3 Bank Stocks Driving Returns Across Industries

FS Bancorp declares $0.26 dividend

FS Bancorp GAAP EPS of $1.06, revenue of $35.45M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>FS Bancorp</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/fsbw-stock-quote/"><strong>FSBW</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>FS Bancorp reported earnings per share of $1.06. This was above the analyst estimate for EPS of 98 cents.</li><li>The company reported revenue of $35.46 million.</li><li>This was 2.77% better than the analyst estimate for revenue of $34.50 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/fsbw-stock-earnings-fs-bancorp-for-q1-of-2024/">FSBW Stock Earnings: FS Bancorp Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>